A historic shift in Canadian drug policy has taken place, as the regulators permit the legalization of psilocybin fungi for therapeutic purposes. Previously, these substances were strictly restricted, but a increasing body of studies suggests they may offer relief for emotional conditions like anxiety. This development represents a key step toward